Earnings Preview For CymaBay Therapeutics
Portfolio Pulse from Benzinga Insights
CymaBay Therapeutics (NASDAQ:CBAY) is set to release its quarterly earnings report on August 10, 2023. Analysts estimate an EPS of $-0.20. The company's past performance shows a pattern of share price changes following earnings reports. The stock is currently trading at $12.4, up 234.63% over the last 52-week period.
August 09, 2023 | 3:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
CymaBay Therapeutics is expected to report an EPS of $-0.20. Past earnings have influenced the share price. The stock is currently trading at $12.4.
The upcoming earnings report is highly relevant to CymaBay Therapeutics as it could influence the stock price. However, the direction of the impact is uncertain as it depends on whether the company beats or misses the EPS estimate and the guidance provided.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100